Spots Global Cancer Trial Database for adenocarcinoma of the bladder
Every month we try and update this database with for adenocarcinoma of the bladder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder | NCT01124682 | Bladder Cancer | diagnostic cyst... diffusion-weigh... implanted fiduc... quality-of-life... 3-dimensional c... image-guided ra... selective exter... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant | NCT00082706 | Bladder Cancer Urethral Cancer Urachal Cancer | 5-Fluorouracil ... Leucovorin Cisplatin Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium | NCT00112905 | Adenocarcinoma ... Distal Urethral... Metastatic Tran... Proximal Urethr... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Regional Transi... Squamous Cell C... Stage III Bladd... Stage IV Bladde... Transitional Ce... Urethral Cancer... | sorafenib tosyl... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer | NCT01196403 | Bladder Cancer | questionnaire a... quality-of-life... robot-assisted ... therapeutic con... therapeutic lap... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium | NCT00112905 | Adenocarcinoma ... Distal Urethral... Metastatic Tran... Proximal Urethr... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Regional Transi... Squamous Cell C... Stage III Bladd... Stage IV Bladde... Transitional Ce... Urethral Cancer... | sorafenib tosyl... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant | NCT00082706 | Bladder Cancer Urethral Cancer Urachal Cancer | 5-Fluorouracil ... Leucovorin Cisplatin Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
| Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer | NCT00002684 | Bladder Cancer Urethral Cancer | cisplatin ifosfamide paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract | NCT00006026 | Bladder Cancer Transitional Ce... Urethral Cancer | rubitecan | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium | NCT00407485 | Adenocarcinoma ... Distal Urethral... Metastatic Tran... Proximal Urethr... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Squamous Cell C... Stage III Bladd... Stage III Ureth... Stage IV Bladde... Transitional Ce... Urethral Cancer... | ziv-aflibercept pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer | NCT01094964 | Bladder Cancer | BCG solution recombinant int... epirubicin hydr... mitomycin C laboratory biom... hyperthermia tr... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
